Dipeptidyl peptidase IV (DPPIV/CD26) inhibition does not improve engraftment of unfractionated syngeneic or allogeneic bone marrow after nonmyeloablative conditioning

In order to develop minimally toxic bone marrow transplantation (BMT) protocols suitable for use in a wider range of indications, it is important to identify ways to enhance BM engraftment at a given level of recipient conditioning. CXCL12/stromal cell-derived factor-1α plays a crucial physiological...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Schwaiger, Elisabeth, Klaus, Christoph, Matheeussen, Veerle, Baranyi, Ulrike, Pilat, Nina, Ramsey, Haley, Korom, Stephan, De Meester, Ingrid, Wekerle, Thomas
Formato: Artigo
Idioma:Inglês
Publicado: Elsevier Science Inc 2012
Assuntos:
Experimental Stem Cell Transplantation
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3265670/
https://ncbi.nlm.nih.gov/pubmed/22085453
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.exphem.2011.10.010
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares